The Cost Analysis Of Aspirin Versus Low Molecular Weight Heparin For Thromboprophylaxis Following Total Hip Arthroplasty

被引：1
|
作者：
Chauhan, Owen
Skedgel, Chris
Pleasance, Susan
Thompson, Kara
Anderson, David
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1134.1134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1134
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Aspirin Versus Low-Molecular-Weight Heparin After Total Hip Arthroplasty
    Granziera, Serena
    Cohen, Alexander T.
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (07) : 502 - 502
  • [2] Dosing and timing of low-molecular-weight heparin thromboprophylaxis in total hip arthroplasty
    Colwell, CW
    ORTHOPEDICS, 2003, 26 (11) : 1155 - 1161
  • [3] Comparison of low molecular weight and PTT adjusted heparin for thromboprophylaxis in patients with total hip and total knee arthroplasty
    Rader, CP
    Kramer, C
    Konig, A
    Gohlke, F
    Eulert, J
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 1997, 135 (01): : 52 - 57
  • [4] COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY
    Delate, T.
    Clark, N.
    Cho, S.
    Witt, D.
    VALUE IN HEALTH, 2011, 14 (03) : A42 - A42
  • [5] Cost-effectiveness of prolonged thromboprophylaxis with low molecular weight heparin in patients undergoing total hip replacement
    Bergqvist, D
    Jönsson, B
    THROMBOSIS AND HAEMOSTASIS, 1999, : 64 - 64
  • [6] Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty A Randomized Trial
    Anderson, David R.
    Dunbar, Michael J.
    Bohm, Eric R.
    Belzile, Etienne
    Kahn, Susan R.
    Zukor, David
    Fisher, William
    Gofton, Wade
    Gross, Peter
    Pelet, Stephane
    Crowther, Mark
    MacDonald, Steven
    Kim, Paul
    Pleasance, Susan
    Davis, Nicki
    Andreou, Pantelis
    Wells, Philip
    Kovacs, Michael
    Rodger, Marc A.
    Ramsay, Tim
    Carrier, Marc
    Vendittoli, Pascal-Andre
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (11) : 800 - +
  • [7] Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty
    Rader, CP
    König, A
    Hendrich, C
    Eulert, J
    JOURNAL OF ARTHROPLASTY, 1998, 13 (02): : 180 - 185
  • [8] Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma
    Chalayer, Emilie
    Bourmaud, Aurelie
    Tinquaut, Fabien
    Chauvin, Franck
    Tardy, Bernard
    THROMBOSIS RESEARCH, 2016, 145 : 119 - 125
  • [9] THE IMPACT OF ADOPTING LOW MOLECULAR WEIGHT HEPARIN IN PLACE OF ASPIRIN AS ROUTINE THROMBOPROPHYLAXIS FOR PATIENTS WITH HIP FRACTURE
    Hoskins, H. C.
    Protty, M. B.
    Hickey, B.
    Lewns, G. J.
    Pettit, R.
    Saad, T.
    Johansen, A.
    AGE AND AGEING, 2019, 48
  • [10] Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
    O'Toole, Robert V.
    Stein, Deborah M.
    O'Hara, Nathan N.
    Frey, Katherine P.
    Taylor, Tara J.
    Scharf-stein, Daniel O.
    Carlini, Anthony R.
    Sudini, Kuladeep
    Degani, Yasmin
    Slobogean, Gerard P.
    Haut, Elliott R.
    Obremskey, Wil-liam
    Firoozabadi, Reza
    Bosse, Michael J.
    Goldhaber, Samuel Z.
    Marvel, Debra
    Castillo, Renan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 203 - 213
12345